Audiologists in Brownwood, TX Accepting Medicare

1 Audiologists found. Showing 1 - 1

Michael Lyle Dugan, BC-HIS Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2410 Crockett Dr Ste A, Brownwood, TX 76801 Phone: 325-641-1825    Fax: 325-641-0716

News Archive

Northeast Ohio healthcare sector companies attracted $132 million in investments in 2010

In 2010, 62 Northeast Ohio companies collectively raised $221 million from venture capitalists and angel investors, an increase of 121 percent over the amount raised by companies in 2009. The growth rate of dollars invested in regional companies is higher than recently released data from Thomson Reuters showing a 19 percent increase in dollars invested nationally.

UK Court gives Smith & Nephew right to Appeal in RENASYS patent litigation

The Advanced Wound Management division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc. notes the finding of the Patents Court of the High Court of Justice of England and Wales in the patent litigation brought by Kinetic Concepts, Inc.. In that case, the Court found that parts of the Smith & Nephew RENASYS™ EZ and RENASYS GO Negative Pressure Wound Therapy (NPWT) Systems have infringed the patents EP0853950 and EP0777504 in the United Kingdom. Today the Court has given Smith & Nephew the right to Appeal this decision. Our full range of RENASYS products remains on the market."

Study unravels molecular mechanism of biomolecule RNA that plays dynamic regulatory role in protein selection

If a big bunch of your brain cells suddenly went rogue and decided to become fat cells, it could cloud your decision-making capacity a bit. Fortunately, early in an organism's development, cells make firm and more-or-less permanent decisions about whether they will live their lives as, say, skin cells, brain cells or, well, fat cells.

New computer algorithm could end misidentification of cancer cells in laboratories

Researchers from the University of Kent have developed a computer algorithm that can identify differences in cancer cell lines based on microscopic images, a unique development towards ending misidentification of cells in laboratories.

FDA releases first draft guidance on Risk Evaluation and Mitigation Strategies for select drugs

The U.S. Food and Drug Administration today announced the availability of the first draft guidance for industry on Risk Evaluation and Mitigation Strategies or REMS, which are required for certain drugs or biologics.

Read more Medical News

› Verified 1 days ago